Cite
Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
MLA
Otsuka M, et al. “Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist.” Thorax, vol. 59, no. 1, Jan. 2004, pp. 31–38. EBSCOhost, https://doi.org/10.1136/thx.2003.000893.
APA
Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S, Otsuka, M., Takahashi, H., Shiratori, M., Chiba, H., & Abe, S. (2004). Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist. Thorax, 59(1), 31–38. https://doi.org/10.1136/thx.2003.000893
Chicago
Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S, M Otsuka, H Takahashi, M Shiratori, H Chiba, and S Abe. 2004. “Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist.” Thorax 59 (1): 31–38. doi:10.1136/thx.2003.000893.